Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Progress in X-linked adrenoleukodystrophy.

Hugo Moser1, Prachi Dubey, Ali Fatemi

  • 1Kennedy Krieger Institute, Baltimore, USA.

Current Opinion in Neurology
|May 29, 2004
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Driving treatment for females with X-linked adrenoleukodystrophy.

Molecular genetics and metabolism·2026
Same author

Normative modeling for quantitative brain MRI phenotyping and biomarker discovery for pediatric leukodystrophies.

medRxiv : the preprint server for health sciences·2026
Same author

A Case of Physiologic Enhancement of Scarpa's Ganglia Mimicking Bilateral Vestibular Schwannomas in a Patient With Atypical Meningioma With NF2 Mutation.

Case reports in radiology·2026
Same author

Evidence of Iron Accumulation in Cerebral Adrenoleukodystrophy: A Potential Novel Disease Mechanism.

Annals of clinical and translational neurology·2026
Same author

Use of Brain MRI in Cerebral Adrenoleukodystrophy: International Recommendations for Screening, Monitoring, and Research.

Neurology·2026
Same author

Living with adrenoleukodystrophy: adult patient and caregiver perspectives.

Orphanet journal of rare diseases·2026
Same journal

Movement disorders and Parkinson's disease: collaborative and interdisciplinary research to advance understanding of neural circuit dysfunction, pathophysiology, and care: new horizons in technology, neuroimaging, neurophysiology, and genetics toward personalized medicine.

Current opinion in neurology·2026
Same journal

Editorial introduction.

Current opinion in neurology·2026
Same journal

Multimodal mapping of balance dysfunction in Parkinson's disease: a consensus roadmap for research and intervention.

Current opinion in neurology·2026
Same journal

Tourette syndrome: brain neurophysiology, circuit dysfunction, and neuromodulation across invasive and noninvasive approaches.

Current opinion in neurology·2026
Same journal

Dystonia: from phenotypes to genetics and therapeutic advances.

Current opinion in neurology·2026
Same journal

What can we learn from eye movements in movement disorders and Parkinson's disease?

Current opinion in neurology·2026
See all related articles

Recent findings on X-linked adrenoleukodystrophy reveal distinct neurological phenotypes and over 500 gene mutations. Emerging therapies like bone marrow transplantation and Lorenzo's oil show promise for treatment and prevention.

Area of Science:

  • Neurology
  • Genetics
  • Biochemistry

Background:

  • X-linked adrenoleukodystrophy (ALD) is a rare genetic disorder affecting the adrenal glands, nervous system, and testes.
  • It is characterized by the accumulation of very long-chain fatty acids (VLC-FAs) in tissues.
  • ALD primarily affects males, but heterozygous females can also exhibit symptoms.

Purpose of the Study:

  • To review and evaluate new information on X-linked adrenoleukodystrophy (ALD) published in 2002 and 2003.
  • To synthesize recent advancements in understanding ALD phenotypes, pathogenesis, diagnosis, and prevention.

Main Methods:

  • Literature review of studies published in 2002-2003.
  • Analysis of genetic mutations and their correlation with clinical phenotypes.

Related Experiment Videos

  • Evaluation of therapeutic interventions, including bone marrow transplantation and Lorenzo's oil.

    • Main Results:

    • ALD presents with two main neurological phenotypes: adrenomyeloneuropathy (adults, non-inflammatory axonopathy) and cerebral myelinopathy (children, inflammatory).
    • Over 500 distinct mutations in the ABCD1 gene have been identified, generally without clear phenotype correlation.
    • Bone marrow transplantation is effective for early cerebral ALD; Lorenzo's oil may prevent neurological decline in young, asymptomatic boys.

    Conclusions:

    • Significant progress has been made in defining ALD phenotypes, understanding its pathogenesis, and improving diagnosis.
    • Emerging therapies offer new avenues for preventing and treating X-linked adrenoleukodystrophy.
    • Continued research is crucial for further advancements in ALD management.